Anabel Franco‐Moreno

767 total citations
48 papers, 276 citations indexed

About

Anabel Franco‐Moreno is a scholar working on Internal Medicine, Infectious Diseases and Neurology. According to data from OpenAlex, Anabel Franco‐Moreno has authored 48 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Internal Medicine, 18 papers in Infectious Diseases and 15 papers in Neurology. Recurrent topics in Anabel Franco‐Moreno's work include Venous Thromboembolism Diagnosis and Management (23 papers), COVID-19 Clinical Research Studies (16 papers) and Long-Term Effects of COVID-19 (12 papers). Anabel Franco‐Moreno is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (23 papers), COVID-19 Clinical Research Studies (16 papers) and Long-Term Effects of COVID-19 (12 papers). Anabel Franco‐Moreno collaborates with scholars based in Spain, Denmark and Italy. Anabel Franco‐Moreno's co-authors include Juan Torres‐Macho, Nuria Muñoz‐Rivas, César Fernández‐de‐las‐Peñas, B. Mestre-Gómez, A. Zapatero Gaviría, José Manuel Ruiz‐Giardín, Jacqueline Veronica Velasco, Kin Israel Notarte, Pablo Ryan and Giuseppe Lippi and has published in prestigious journals such as The Journals of Gerontology Series A, Journal of Medical Virology and Health and Quality of Life Outcomes.

In The Last Decade

Anabel Franco‐Moreno

39 papers receiving 272 citations

Peers

Countries citing papers authored by Anabel Franco‐Moreno

Since Specialization

Citations

This map shows the geographic impact of Anabel Franco‐Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anabel Franco‐Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anabel Franco‐Moreno more than expected).

Fields of papers citing papers by Anabel Franco‐Moreno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anabel Franco‐Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anabel Franco‐Moreno. The network helps show where Anabel Franco‐Moreno may publish in the future.

Co-authorship network of co-authors of Anabel Franco‐Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of Anabel Franco‐Moreno. A scholar is included among the top collaborators of Anabel Franco‐Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anabel Franco‐Moreno. Anabel Franco‐Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Riesgo de tromboembolia venosa en población transgénero en terapia hormonal: una revisión sistemática y metaanálisis 2025 ·Medicina Clínica ·Anabel Franco‐Moreno, (unknown), Nuria Muñoz‐Rivas, (unknown), Juan Torres‐Macho, (unknown)	1
2	A Digital Twin Strategy to Predict Thrombotic Recurrence in Antiphospholipid Syndrome Patients Treated with Direct Oral Anticoagulants vs. Vitamin K Antagonists Using Data from Real-World Populations 2025 ·Journal of Clinical Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Anabel Franco‐Moreno	0
3	External validation of the RIETE and SOME scores for occult cancer in patients with venous thromboembolism: a multicentre cohort study 2024 ·Clinical & Translational Oncology ·Anabel Franco‐Moreno, (unknown), (unknown), (unknown), Nuria Muñoz‐Rivas, Ana Isabel Farfán‐Sedano, (unknown), Juan Torres‐Macho, (unknown), (unknown), José Manuel Ruiz‐Giardín, (unknown)	3
4	Correction: Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review 2024 ·Infection ·César Fernández‐de‐las‐Peñas, Juan Torres‐Macho, Jesus Alfonso Catahay, (unknown), Jacqueline Veronica Velasco, (unknown), Mario Caldararo, Brandon Michael Henry, Giuseppe Lippi, Anabel Franco‐Moreno, Kin Israel Notarte	1
5	Presence of SARS‐CoV‐2 RNA in COVID‐19 survivors with post‐COVID symptoms 2 years after hospitalization: The VIPER study 2024 ·Journal of Medical Virology ·César Fernández‐de‐las‐Peñas, Juan Torres‐Macho, María Ruiz‐Ruigómez, (unknown), (unknown), (unknown), (unknown), Pablo Ryan, Carlos Lumbreras, Óscar J. Pellicer-Valero, Rocco Giordano, Lars Arendt‐Nielsen, Anabel Franco‐Moreno	5
6	Inflammatory Polymorphisms (IL-6 rs1800796, IL-10 rs1800896, TNF-α rs1800629, and IFITM3 rs12252) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors 2024 ·Viruses ·César Fernández‐de‐las‐Peñas, Gema Dı́az-Gil, (unknown), (unknown), Silvia Ambite‐Quesada, Juan Torres‐Macho, Pablo Ryan, Anabel Franco‐Moreno, Óscar J. Pellicer-Valero, Lars Arendt‐Nielsen, Rocco Giordano	3
7	DNA Methylation Levels of the ACE2 Promoter Are Not Associated with Post-COVID-19 Symptoms in Individuals Who Had Been Hospitalized Due to COVID-19 2024 ·Microorganisms ·César Fernández‐de‐las‐Peñas, Gema Dı́az-Gil, (unknown), (unknown), Silvia Ambite‐Quesada, Juan Torres‐Macho, Pablo Ryan, Anabel Franco‐Moreno, Óscar J. Pellicer-Valero, Lars Arendt‐Nielsen, Rocco Giordano	0
8	Development of a Predictive Model of Occult Cancer After a Venous Thromboembolism Event Using Machine Learning: The CLOVER Study 2024 ·Medicina ·Anabel Franco‐Moreno, (unknown), (unknown), Ana Isabel Farfán‐Sedano, A. Rivas, (unknown), José Manuel Ruiz‐Giardín, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
9	Prediction of Venous Thromboembolism in Patients With Cancer Using Machine Learning Approaches: A Systematic Review and Meta-Analysis 2023 ·JCO Clinical Cancer Informatics ·Anabel Franco‐Moreno, (unknown), Nuria Muñoz‐Rivas, Juan Torres‐Macho, José Manuel Ruiz‐Giardín, (unknown)	9
10	Serological Biomarkers at Hospital Admission and Hospitalization Treatments Are Not Related to Sensitization-Associated Symptoms in Patients with Post-COVID Pain 2023 ·Pathogens ·César Fernández‐de‐las‐Peñas, Carlos Guijarro, Juan Torres‐Macho, Óscar J. Pellicer-Valero, Anabel Franco‐Moreno, Jo Nijs, María Velasco	1
11	Clinical prediction model for pulmonary thrombosis diagnosis in hospitalized patients with SARS-CoV-2 infection 2023 ·Journal of Clinical and Translational Research ·Anabel Franco‐Moreno, (unknown), (unknown), (unknown), (unknown), (unknown), Nuria Muñoz‐Rivas, (unknown), José Manuel Ruiz‐Giardín, (unknown), (unknown), (unknown), Juan Torres‐Macho, (unknown)	1
12	Utility of probability scores for the diagnosis of pulmonary embolism in patients with SARS-CoV-2 infection: A systematic review 2022 ·Revista Clínica Española (English Edition) ·Anabel Franco‐Moreno, (unknown), José Manuel Ruiz‐Giardín, Nuria Muñoz‐Rivas, Juan Torres‐Macho, (unknown)	4
13	El hospital como centro promotor de espacios sin humo: Estrategias dirigidas al control del tabaquismo 2020 ·Revista Española de Salud Pública ·(unknown), (unknown), María Esteve, (unknown), (unknown), (unknown), (unknown), Ignasi García-Olivé, (unknown), (unknown), Rosario López‐Rodríguez, (unknown), Anabel Franco‐Moreno, (unknown), Luis Rodriguez, (unknown), (unknown), (unknown)	0
14	Application of Telemedicine for the Control of Patients with Acute and Chronic Heart Diseases 2018 ·Telemedicine Journal and e-Health ·(unknown), Anabel Franco‐Moreno	12
15	Metastatic Thymic Carcinoma with Long Survival After Treatment with Sunitinib 2018 ·Cureus ·Luis Cabezón‐Gutiérrez, Parham Khosravi‐Shahi, (unknown), (unknown), (unknown), Anabel Franco‐Moreno	1
16	Anticoagulantes orales directos: puesta al día 2017 ·Medicina Clínica ·Anabel Franco‐Moreno, (unknown), (unknown)	29
17	Riesgo de recurrencia en el tromboembolismo venoso idiopático 2016 ·Revista Clínica Española ·Anabel Franco‐Moreno, (unknown), (unknown)	2
18	Clinical Case of Metastatic Adrenocortical Carcinoma With Unusual Evolution: Review the Literature 2015 ·World Journal of Oncology ·Luis Cabezón‐Gutiérrez, Anabel Franco‐Moreno, Parham Khosravi‐Shahi, (unknown), (unknown), (unknown)	2
19	Place of residence before hospital admission and mortality at 12‐months in Spanish patients aged 70 years or older 2012 ·Geriatrics and gerontology international ·(unknown), (unknown), (unknown), Ana Isabel Farfán‐Sedano, Anabel Franco‐Moreno, Ana Benavente, A. Zapatero Gaviría	3
20	Estudio sobre la prevalencia del burnout en los médicos del Área Sanitaria de Talavera de la Reina 2003 ·Atención Primaria ·(unknown), (unknown), Anabel Franco‐Moreno, (unknown)	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact